Andrés Moret

One‐stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

Ana Rosa Cid, Mar. G. Calabuig, Vicente Cortina et al. · Haemophilia · 2008 · 60 citations

Immunohematology, Genetics, Genetic Epidemiology +16

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients

Nina Borràs, Javier Batlle, Almudena Pérez‐Rodríguez et al. · Haematologica · 2017 · 54 citations · Full text

Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm

Javier Batlle, Almudena Pérez‐Rodríguez, Irene Corrales et al. · Thrombosis and Haemostasis · 2015 · 44 citations · Full text

Genetics, Genetic Epidemiology, Pathology +22

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method

N. Cabrera, Andrés Moret, P. Caunedo et al. · Haemophilia · 2013 · 35 citations

Head‐to‐head comparison of the pharmacokinetic profiles of a high‐purity factor IX concentrate (AlphaNine^®) and a recombinant factor IX (BeneFIX^®) in patients with severe haemophilia B

Toshko Lissitchkov, Michał Matysiak, K. Zavilska et al. · Haemophilia · 2013 · 27 citations